Resultats de la cerca - David Feifel
- Mostrar 1 - 18 resultats de 18
-
1
Oxytocin in schizophrenia: a review of evidence for its therapeutic effects per Kai MacDonald, David Feifel
Publicat 2011Revisão -
2
-
3
Potential of Oxytocin in the Treatment of Schizophrenia per Paul D. Shilling, David Feifel
Publicat 2016Revisão -
4
-
5
-
6
The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup per Michael P. Wilson, David Pepper, Glenn W. Currier, Garland Holloman, David Feifel
Publicat 2012Artigo -
7
-
8
-
9
A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment‐resistant depression per Terry Schwartz, Mary Ellen Trunko, David Feifel, Emily Lopez, Danika Peterson, Guido Frank, Walter H. Kaye
Publicat 2021Artigo -
10
-
11
-
12
Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine per Michael D. Lesem, Tram Tran-Johnson, Robert Riesenberg, David Feifel, Michael H. Allen, Robert Fishman, Daniel A. Spyker, John H. Kehne, James V. Cassella
Publicat 2011Artigo -
13
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication per Guy M. Goodwin, Megan Croal, David Feifel, John R. Kelly, Lindsey Marwood, Sunil Mistry, Veronica O’Keane, Stephanie Knatz Peck, Hollie Simmons, Claudia Sisa, S. C. Stansfield, Joyce Tsai, Sam Williams, Ekaterina Malievskaia
Publicat 2023Artigo -
14
Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial per Lior Carmi, Aron Tendler, Alexander Bystritsky, Eric Hollander, Daniel M. Blumberger, Jeff Daskalakis, Herbert E. Ward, Kyle Lapidus, Wayne K. Goodman, Leah Casuto, David Feifel, Noam Barnea‐Ygael, Yiftach Roth, Abraham Zangen, Joseph Zohar
Publicat 2019Artigo -
15
Pursuing personalized medicine for depression by targeting the lateral or medial prefrontal cortex with Deep TMS per Abraham Zangen, Samuel Zibman, Aron Tendler, Noam Barnea‐Ygael, Uri Alyagon, Daniel M. Blumberger, Geoffrey Grammer, Hadar Shalev, Tatiana Gulevski, Tanya Vapnik, Alexander Bystritsky, Igor Filipčić, David Feifel, Ahava Stein, Frederic Deutsch, Yiftach Roth, Mark S. George
Publicat 2023Artigo -
16
Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double‐blind randomized controlled trial per Abraham Zangen, Hagar Moshe, Diana Martínez, Noam Barnea‐Ygael, Tanya Vapnik, Alexander Bystritsky, Walter Duffy, Doron Toder, Leah Casuto, Moran Lipkinsky Grosz, Edward V. Nunes, Herbert E. Ward, Aron Tendler, David Feifel, Oscar Morales, Yiftach Roth, Dan V. Iosifescu, Jaron L. Winston, Theodore Wirecki, Ahava Stein, Frederic Deutsch, Xingbao Li, Mark S. George
Publicat 2021Artigo -
17
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life per Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James Bennett, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, M. Ishrat Husain, John R. Kelly, Molly Lennard-Jones, Rasmus Wentzer Licht, Lindsey Marwood, Sunil Mistry, Tomáš Páleníček, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie Simmons, Jair C. Soares, Metten Somers, S. C. Stansfield, Jessica R. Stuart, Hannah H. Tadley, Nisha K. Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I. Winzer, Allan H. Young, Matthew B. Young, Sid Zisook, Ekaterina Malievskaia
Publicat 2023Artigo -
18
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression per Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Peter C. Arden, Annie Baker, James Bennett, Catherine Bird, Renske E. Blom, Christine Brennan, Donna Brusch, Lisa Burke, Kete Campbell‐Coker, Robin Carhart‐Harris, Joseph Cattell, Aster Daniel, Charles DeBattista, Boadie W. Dunlop, Katherine Eisen, David Feifel, MacKenzie Forbes, Hannah M. Haumann, David J. Hellerstein, Astrid I. Hoppe, M. Ishrat Husain, Luke A. Jelen, Jeanine Kamphuis, Julie Kawasaki, John R. Kelly, Richard E. Key, Ronit Kishon, Stephanie Knatz Peck, Gemma Knight, Martijn H.B. Koolen, Melanie Lean, Rasmus Wentzer Licht, Jessica L. Maples‐Keller, Jan Mars, Lindsey Marwood, Martin McElhiney, Tammy Miller, Arvin Mirow, Sunil Mistry, Tanja Mletzko, Liam N. Modlin, René Ernst Nielsen, Elizabeth M. Nielson, Sjoerd R. Offerhaus, Veronica O’Keane, Tomáš Páleníček, David Printz, Marleen C. Rademaker, Aumer van Reemst, Frederick Reinholdt, Dimitris Repantis, James Rucker, Samuel Rudow, Simon Ruffell, A. John Rush, Robert A. Schoevers, Mathieu Seynaeve, Samantha Shao, Jair C. Soares, Metten Somers, S. C. Stansfield, Diane Sterling, Aaron Strockis, Joyce Tsai, Lucy Visser, Mourad Wahba, Samuel P. Williams, Allan H. Young, Paula Ywema, Sidney Zisook, Ekaterina Malievskaia
Publicat 2022Artigo
Eines de cerca:
Matèries relacionades
Medicine
Psychiatry
Psychology
Internal medicine
Neuroscience
Cognition
Pathology
Anxiety
Clinical trial
Oxytocin
Schizophrenia (object-oriented programming)
Alternative medicine
Biology
Placebo
Anesthesia
Antipsychotic
Depression (economics)
Economics
Pharmacology
Adverse effect
Antidepressant
Clinical endpoint
Clinical psychology
Hallucinogen
Macroeconomics
Psilocybin
Psychosis
Randomized controlled trial
Treatment-resistant depression
Clinical Global Impression